4 trends tracked about this subject — the full history, oldest to newest below.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
The FDA has placed a clinical hold on Regenxbio's gene therapy for Hunter Syndrome following safety concerns related to spine MRI findings.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
The FDA is allowing Regenxbio to resubmit its gene therapy for Hunter syndrome, marking a reversal of a previous rejection.